Crew members of the Inspiration4 mission, which will be the first human-civilian spaceflight, have agreed that they would collect and test blood samples during their trip around the Earth.
On September 15, the crew of four will take off from SpaceX Crew Dragon spacecraft. The crew of four will not dock with the Crew Dragons usual destination, the International Space Station. Instead, they'll be orbiting the Earth for three days at an altitude of 337 miles.
That'll be the farthest human spaceflight has been from Earth since NASA sent astronauts aboard the Space Shuttle to repair Hubble Space Telescope for the fifth time in 2009.
SpaceX is collaborating with NASA-funded Translational Research Institute for Space Health at the Baylor College of Medicine (TRISH), and Weill Cornell Medicine to gather important biomedical and environmental data during this historic flight.
Advertisement
Advertisement
Crew members will be asked to take measurements of heart rate, rhythm, cabin noise and light intensity during spaceflight. This is to determine how their immune systems react to spaceflight.
The crew will use a state of the art device called the Vertical Flow Immunoassay to take samples. This small device can detect antigens quickly in a sample.
To scan their organs, the crew will also use an AI powered ultrasound device called ButterflyIQ+. This is done to see if civilians are capable of taking their own images, even if they need external assistance during spaceflight.
The crew is aware that it is a historic moment to have a civilian crew spend several days in space.
Advertisement
Advertisement
Commander Jared Isaacman, who also funds the mission, stated that the crew of Inspiration4 is keen to make the future better for all who launch over the coming decades and years.
He said that fewer than 600 people have ever reached space in all of human history. We are proud of our flight and look forward for the opportunity to influence those who follow us.
More about the mission: A billionaire buys a SpaceX ticket to make space beer in an absurd PR stunt
